Top compounds associated with response to TCF19


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA XL765 CTRPv2 pan-cancer AAC 0.12 0.003
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.12 0.003
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.091 0.004
mRNA VAF-347 CTRPv2 pan-cancer AAC -0.14 0.004
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.096 0.004
mRNA MST-312 CTRPv2 pan-cancer AAC 0.1 0.004
mRNA SID 26681509 CTRPv2 pan-cancer AAC 0.11 0.004
Download CSV